Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoHorizons is a nanotechnology company specializing in the development and manufacture of advanced antimicrobial additives for the healthcare, textile, and industrial markets. The company's flagship technology, SmartSilver, utilizes engineered silver nanoparticles to provide permanent antimicrobial protection and odor control. These additives are designed to be integrated directly into the manufacturing process of various materials, including synthetic fibers, polymers, and coatings, without altering their physical properties. NanoHorizons' products are widely used in medical applications such as wound dressings and catheters to prevent healthcare-associated infections. In 2015, the company was acquired by Sciessent, a global leader in antimicrobial and odor-control solutions, to expand its technology portfolio. Today, the SmartSilver brand continues to be a key component of Sciessent's offerings in the global marketplace.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NanoHorizons.